Improving neurological outcome after spinal cord injury is a major clinical challenge because axons, once severed, do not regenerate but 'dieback' from the lesion site. Although microglia, the immunocompetent cells of the brain and spinal cord respond rapidly to spinal cord injury, their role in subsequent injury or repair remains unclear. To assess the role of microglia in spinal cord white matter injury we used time-lapse two-photon and spectral confocal imaging of green fluorescent proteinlabelled microglia, yellow fluorescent protein-labelled axons, and Nile Red-labelled myelin of living murine spinal cord and revealed dynamic changes in white matter elements after laser-induced spinal cord injury in real time. Importantly, our model of acute axonal injury closely mimics the axonopathy described in well-characterized clinically relevant models of spinal cord injury including contusive-, compressive-and transection-based models. Time-lapse recordings revealed that microglia were associated with some acute pathophysiological changes in axons and myelin acutely after laser-induced spinal cord injury. These pathophysiological changes included myelin and axonal spheroid formation, spectral shifts in Nile Red emission spectra in axonal endbulbs detected with spectral microscopy, and 'bystander' degeneration of axons that survived the initial injury, but then succumbed to secondary degeneration. Surprisingly, modulation of microglial-mediated release of neurotoxic molecules failed to protect axons and myelin. In contrast, sterile stimulation of microglia with the specific toll-like receptor 2 agonist Pam2CSK4 robustly increased the microglial response to ablation, reduced secondary degeneration of central myelinated fibres, and induced an alternative (mixed M1:M2) microglial activation profile. Conversely, Tlr2 knock out: Thy1 yellow fluorescent protein double transgenic mice experienced greater axonal dieback than littermate controls. Thus, promoting an alternative microglial response through Pam2CSK4 treatment is neuroprotective acutely following laser-induced spinal cord injury. Therefore, anti-inflammatory treatments that target microglial activation may be counterintuitive after spinal cord injury.
Introduction
Microglia respond rapidly to injury; however, their role in acute secondary white matter injury or repair after spinal cord injury (SCI) remains poorly understood. Live imaging studies have shown that microglia survey their environment and respond within minutes to injury (Davalos et al., 2005; Nimmerjahn et al., 2005) ; this response may be beneficial because inhibiting microglial process extension results in larger lesions in brain slices (Hines et al., 2009) . Furthermore, transplanting microglia (Prewitt et al., 1997; Rabchevsky and Streit, 1997) or macrophages (Rapalino et al., 1998) after CNS insult or stimulating macrophages with Toll-like receptor (TLR) agonists (e.g. zymosan) improves axonal sprouting/regeneration in some paradigms (Leon et al., 2000; Ahmed et al., 2010; Hauk et al., 2010) .
In contrast, numerous studies have shown that microglia and blood-derived macrophages release potent neurotoxins after injury (e.g. reactive oxygen species; nitric oxide and the formation of peroxynitrite; cytokines such as TNF-alpha and IL1B; and glutamate) (Giulian et al., 1993; Satake et al., 2000; Taylor et al., 2003; Bao et al., 2004; Yawata et al., 2008) . In support, activation of microglia/macrophages through TLRs induces neuronal cell death and neurite degeneration (Fitch et al., 1999; Lehnardt et al., 2002; Popovich et al., 2002) . As white matter elements are sensitive to these neurotoxins, treatments aimed at reducing the microglial/ macrophage response and subsequent neurotoxicity are often protective (Blight, 1994; Popovich et al., 1999; Park et al., 2004; Domercq et al., 2007; Byrnes et al., 2009) and prevent the second late phase of axonal dieback (Stirling et al., 2004; Horn et al., 2008) .
TLRs, a large family of pattern recognition receptors, respond to both 'danger' and 'stranger' signals (Kawai and Akira, 2010) . TLR2 and TLR4 signalling in microglia/macrophages induces these cells to secrete pro-inflammatory cytokines as well as other potentially toxic molecules (Lehnardt, 2010) . Based on these divergent roles of microglia/macrophages in CNS injury, we hypothesized that specifically targeting microglia in isolation of monocyte-derived macrophages, by inhibiting their neurotoxic release of glutamate and other inflammatory factors, would protect spinal cord white matter. Conversely, stimulating microglia by potent TLR agonists would promote white matter injury.
Two-photon excitation time-lapse video microscopy revealed that the microglial response spatially and temporally correlated with ongoing secondary degeneration (i.e. axonal dieback and secondary 'bystander' degeneration of axons that survived the initial ablation but later succumbed to axonal degeneration). Remarkably, treatments that have previously been shown to reduce microglial-mediated glutamate release and reduce their neurotoxicity, failed to protect axons or prevent their dieback following laser-induced SCI. Conversely stimulating microglia with the specific TLR2 agonist Pam2CSK4, but not other TLR receptor agonists, augmented the microglial response to laser-induced SCI, polarized microglia to an alternative protective (mixed M1:M2) phenotype, and preserved white matter elements.
Taken together, these observations suggest that microglial responses in isolation after SCI are ineffective at protecting vital white matter elements. However, their typical activation states can be boosted and biased towards a beneficial profile through specific TLR2 agonists. A better understanding of the mechanisms behind these divergent TLR2 stimulated responses and which stimuli result in beneficial reactions, will potentially guide therapeutic interventions to improve neurological outcome after SCI.
Materials and methods

Ex vivo whole spinal cord model
All experiments were conducted in accordance with the University of Calgary Animal Care Ethics Committee, adhering to the guidelines of the Canadian Council on Animal Care. Adult 6-8 week old heterozygous Cx3cr1 GFP/ + mice (Jung et al., 2000) (a kind gift from Dr Paul Kubes) were used to visualize microglia, Thy1YFP + mice (Feng et al., 2000) (a kind gift from Dr Douglas Zochodne) were used to visualize dorsal column axons, or Cx3cr1 GFP/ + : Thy1YFP + double transgenic mice bred in house to visualize both microglia and axons simultaneously, were used for all imaging experiments. The transgenic mice were backcrossed to C57BL/6 mice for at least 10 generations. Tlr2-knockout (Tlr2KO) mice (a kind gift from Dr Paul Kubes) were bred inhouse with Thy1YFP + to produce Tlr2KO:Thy1YFP + double transgenic mice and Tlr2wildtype:Thy1YFP + double transgenic mice littermate controls used for all experiments. Genotyping confirmed the genotype of all mice in the experiments. Mice were deeply anaesthetized with an intraperitoneal injection of sodium pentobarbital (Ceva Sante Animale) and perfused transcardially (1 ml/min) with ice cold low Ca 2 + artificial CSF (in mM: NaCl 126, NaHCO 3 26, KCL 3, NaH 2 PO 4 1.25, MgSO 4 2, CaCl 2 0.1, and dextrose 10) bubbled in 95% O 2 /5% CO 2 to remove blood and keep the spinal cord viable during the dissection. After the removal of the skin and hair, an incision was made through the skull and a multi-segment laminectomy was made using forceps and fine scissors to expose the dorsal surface of the spinal cord from the brainstem to the lumbar region without damaging the underlying myelinated fibres. Using a fine-tipped scalpel blade, the spinal cord at the mid-thoracic level and at the level of the brainstem was transected. After transection, the underlying vertebral column was cut to isolate the spinal cord and supported by a vertical slice to clamp the exposed bones within a customized imaging chamber (RC-27L Large Bath Chamber, Harvard Apparatus) ( Supplementary  Fig. 1 ). The spinal cord was then continuously perfused ($1.5 ml/min) for the remainder of the imaging experiments in normal 2 mM Ca 2 + artificial CSF bubbled with 95% O 2 /5% CO 2 , and maintained at 36.5 C through an in-line heater equipped with temperature feedback control (Harvard Apparatus) and an objective heater system (Bioptechs Inc.) ( Supplementary Fig. 1 ). Using this set-up, the ex vivo spinal cord remained viable for up to 12 h after injury. To visualize myelin, the lipophilic dye Nile Red (N-1142, Life Technologies Inc.) was dissolved in dimethyl sulphoxide and used at a final concentration of 25 mM, then directly and briefly added to the perfusion chamber. To eliminate oversaturation or to avoid poor myelin labeling, Nile Red was added directly to the perfusion chamber in 2 -ml volumes, left for 2-5 min to penetrate the spinal cord, and repeated until adequate and specific labelling of myelin was achieved. Once the initial labelling of myelin was achieved, Nile Red was added once again at 2 h after laserinduced SCI until clear labelling of myelin surrounding yellow fluorescent protein (YFP)-positve axon profiles was achieved. Importantly, using this experimental perfusion system, the spinal cord in isolation remained viable up to 12 h after laser-induced SCI based on morphological observation of axons, myelin and microglia (data not shown).
Microscopy
Time-lapse two-photon excitation images of fluorescently labelled samples were obtained by using a custom-modified commercial system (Nikon D-Eclipse C1, Nikon Instruments). Spinal cords were then excited with 50-fs pulses with wavelengths of 950 nm (GFP, YFP and Nile Red) at 10-15 mW generated by a Ti:sapphire laser (Tsunami, Spectra-Physics Lasers) through a water-immersion objective Â 60 1.0 NA, Fluor (Nikon) for visualizing fluorescent proteins and dyes. The fluorescence emitted was filtered through 525/25 nm band-pass and 590 nm long-pass filters (Chroma Technologies) to a pair of photomultiplier tubes for detection (Hamamatsu R5929). For some preparations, after two-photon excitation imaging, the chamber containing the spinal cords were transferred to a Nikon C1si spectral laser scanning confocal microscope to collect spectral data (emission spectra separated into 32 bins) of fluorescent proteins and dyes using the ablation site as a reference. As Nile Red, our lipophilic vital myelin probe, undergoes solvatochromism dependent on its chemical environment, we took advantage of this property to assess changes in myelin and axons after injury. We noted that transected axonal endbulbs, but not normal axons fluoresce brightly with Nile Red and the emission maxima was shifted to 630 nm compared with myelin and adipocytes (emission maxima 580-90 nm). These Nikon files were also imported into Imagetrak software and 'unmixed' using the spectral manager function of the software (written by P.K.S.). Thus, using our unmixing algorithm overlapping emission spectra such as GFP and YFP could be easily separated as long as the emission maxima were separated by 10 nm. Similarly, Nile Red shifts 410 nm could be unmixed in a similar fashion.
Laser-induced spinal cord injury
Baseline time-lapse recordings of the middle of the cervical enlargement were obtained 30 min to 1 h after initial alignment under the two-photon microscope. Using Nikon software (EZ-C1), the area of the proposed ablation site was magnified Â 11.9 (17.81 Â 17.81 mm, area = 317.20 mm 2 ) and the laser wavelength tuned to 800 nm, 50-75 mW for 10 passes (1.92 ms pixel dwell time), to produce a highly focal and intense laser pulse to completely transect dorsal column axons. After ablation, the laser wavelength was tuned to 950 nm and power reduced to 10-15 mW as detailed above for time-lapse recordings.
Pharmacological agents
Lipopolysaccharide (TLR4 agonist, 100 ng/ml) and zymosan A (TLR2/ dectin-1 agonist, 100 ng/ml) were purchased from Sigma; Pam2CSK4 (TLR2 agonist, 100 ng/ml) was purchased from InvivoGen; carbenoxolone (a gap junction blocker, 200 mM, used to prevent glutamate release; Yawata et al., 2008) , L-AP4, a selective group III metabotropic glutamate receptor agonist, 100 mM, to prevent microglial release of neurotoxins (Taylor et al., 2003) , cycloheximide (selective inhibitor of protein synthesis, 50 mM) were purchased from Tocris. These agents were then solubilized, diluted and stored as per manufacturer's recommendations. All pharmacological agents were added at the indicated concentrations and continuously perfused 30 min before laserinduced SCI until 4 h after laser-induced SCI. The concentration of agonists was approximated based on what was previously used to elicit responses in myeloid cells in vitro (Pinteaux-Jones et al., 2008; Yawata et al., 2008; Long et al., 2009) . For example both lipopolysaccharide and Pam2CSK4 at 100 ng/ml (as used in the present study) induced activation of MAP kinase and NF-B signalling pathways and inflammatory cytokine expression in the murine macrophage/ monocyte cell line Raw 264.7, and bone marrow-derived macrophages from C57BL/6 mice (Long et al., 2009) . Importantly, the effects of Pam2CSK4 were TLR2 specific as Pam2CSK4 was unable to induce activation of the above signalling pathways in macrophages from Tlr2 À / À mice (Long et al., 2009) . However, assessment of a more extensive dose range of the agonists used in the study should be the focus of future experiments to compliment these studies.
Image analysis
To quantify axonal dieback, ablation width, ablation area, and width of axon loss ('bystander' loss of adjacent axons), time-lapse recordings of the entire ablation field were collected in z-stacks (0.6 mm/step size; 0.174 mm/pixel) at baseline, 2 min, 5 min, 30 min, 1 h, 2 h, 3 h and 4 h after laser-induced SCI and the 4D image data were then imported into ImageTrak (written by P.K.S.) for visualization and analysis on a Macintosh OS X computer. Image stacks were autoregistered to reduce movement artefacts caused during image acquisition. The distance of dieback of individual axons proximal (caudal) to the ablation site over time was measured using a distance tool. Only endbulbs that were clearly connected to a proximal axonal stalk were included in the analysis to avoid including fragments of degenerating axons. The distance between the endbulb and the ablation edge was recorded.
A total of n = 39-141 axonal endbulbs per group, from 4-14 animals per group, were analysed and expressed as median and 25th and 75th percentile (box and whisker plots). As Nile Red reliably labelled the ablation site and the ablation site did not change over 4 h after laserinduced SCI, we measured the ablation width and area using a distance and area tool respectively, on five individual adjacent images centred over the middle of the ablation over time. A total of n = 14-26 ablation sites from 14-26 animals were analysed and expressed as mean AE SEM. To quantify 'bystander' loss of axons adjacent to the ablation site that survived the initial injury, but then succumbed to secondary degeneration, we measured the width of axonal loss using a distance tool on individual images at the centre of the ablation site. The width of axonal loss was calculated as the total lesion width (distance between the closest intact axons on both sides of the ablation site) minus the ablation site width (contains primary injured axons). A total of n = 4-14 ablation sites from 4-14 animals per group were analysed and expressed as mean AE SEM. All experimenters that analysed images in this study were blind to treatment. See Table 1 for a complete description of each group used for image analysis. As each vehicle control for each treatment group had slightly different solvents and no differences were determined between the different solvents they were pooled for analysis.
Microglia quantification
To quantify the microglial response to laser-induced SCI, we used a similar approach to document the microglial response in the brain (Davalos et al., 2005) . Similar to the microglial response to brain injury, spinal cord white matter microglia respond to laser-induced SCI by rapidly orientating their processes towards the ablation site to surround or seal of the injury. Time-lapse recordings from each treatment group were opened in ImageTrak software and maximum intensity plots were created from baseline, 2 min, 5 min, 30 min, 1 h, 2 h, 3 h, and 4 h following laser-induced SCI. The maximum intensity plots were produced from the centre of the laser ablation site as determined in the z-plane and included a total of 17 sections surrounding the ablation site with a z-step size of 0.6 mm giving a total depth of 10.2 mm. To subtract Nile Red signal leakage within the green (GFP) channel, image math was performed on all images using the following formula, green channel = g À (25 Â r), where g = GFP channel and r = Nile Red channel. This approach greatly reduced Nile Red leakage signal within the green channel to allow for a purer collection of true microglial signal. A mask channel (blue) was then used to threshold all the images uniformly to maximize signal to noise in the green channel.
The maximum intensity plots from each time-point was then analysed as follows. Using a circular poly tool in ImageTrak, three circles were created on the maximum intensity plots to outline the ablation site (ablation poly, 40 -mm diameter to subtract fluorescence signal from the ablation), adjacent to the lesion site (x-poly, 75-mm diameter) to assess the movement of microglia processes towards the edges of the lesion and an outer ring poly (y-poly, 100-mm diameter) to determine the starting microglial position. We then calculated the microglial response to laser-induced SCI using the following formula: Microglia response = R(t) = (Rx(t) À Rx(0) / Ry(0), where x = inner shell y = outer shell t = time, 0 = baseline. Four to five spinal cords per treatment group were compared.
Quantitative polymerase chain reaction
At 4 h after laser-induced SCI, the dorsal columns containing the ablation site from n = 3-4 animals/group were flash frozen in liquid N 2 and stored at À 80 C before use. The tissue samples for RNA were homogenized in TRIzol Õ reagent (Invitrogen) using, successively, 20 G and 25 G needles and stored at À 80 C prior to use. RNA was extracted using the RNeasy Õ Mini Kit columns (Qiagen), and for quantitative PCR, RNA was first treated with DNase (Promega) and reverse transcribed using SuperScript Õ II reverse transcriptase (Invitrogen). The resulting complementary DNA was used as a template for the BioRad iCycler detection system and 2 Â SYBR green mastermix (Qiagen). Every primer (10Â QuantiTect Primer Assay) that was used was purchased from Qiagen and details can be found on their website. Expression of gene transcripts were normalized against the housekeeping gene, GAPDH. Relative expression levels for our genes of interest were determined using the formula 2 À ÁCT where ÁCT = CT (gene of interest) À CT (housekeeping gene).
Flow cytometry
At 4 h after laser-induced SCI, cells from the dorsal columns that contained the ablation site were separated into neural and leucocyte populations by discontinuous density gradient centrifugation using isotonic Percoll Õ (GE Healthcare). CNS cell samples were prepared at 4 C in buffer solution (fluorescence-activated cell sorting buffer) and stained with antibodies against CD45, CD11b and Ly6C. The percentage of pro-inflammatory microglia (M1, CD45low, CDllb + , Ly6C high ) were compared between sham and treatments groups (n = 3-4/ group). Antibodies and their isotype controls were purchased from BD Bioscience. Isotype controls were always included in the assays. Cells were incubated for 45 min in a combination of directly conjugated antibodies at 4 C. Data acquisition was performed on a flow cytometer (BD FACSAria; BD Biosciences) and analysed with FlowJo (TreeStar) software blind to treatment group.
Statistics
All treatment groups were compared and graphs produced using SigmaPlot 11 (Systat Software, Inc.) . Axonal dieback data were tested using a Kruskal-Wallis one-way ANOVA on Ranks with Dunn's method of multiple comparisons versus artificial CSF control group as the data failed normality. Width of axonal loss was compared between groups using an ANOVA, with a Holm Sidak multiple comparisons versus artificial CSF control or in the case of normality or equal variance test failure, Kruskal-Wallis one-way ANOVA on Ranks with Dunn's method of multiple comparisons versus artificial CSF control group was used. Ablation area, ablation width, and width of axonal loss from artificial CSF-treated spinal cords were compared over time using a repeated measures ANOVA and multiple comparisons versus control group (Holm-Sidak method). For the microglial response, quantitative PCR, and flow cytometry, treatment groups were compared using an ANOVA and multiple comparisons versus control group (Holm-Sidak method). P 5 0.05 was considered statistically significant.
Results
Microglia and central myelinated fibre response to laser-induced spinal cord injury
We developed an ex vivo laser-induced SCI model to isolate the microglial response from blood-derived immune cells to directly assess the microglial response to injury without confounding effects from blood-derived macrophages. By combining twophoton excitation and spectral confocal microscopy to spectrally 'unmix' closely spaced fluorescent probes, we documented changes in axons, microglia and myelin after injury in real-time using heterozygous transgenic mice that express GFP in microglia (Cx3cr1 GFP/ + ), YFP in axons (Thy1YFP + ) or double transgenic mice (Cx3cr1 GFP/ + :Thy1YFP + ). Normal myelin, damaged myelin, and transected axonal endbulbs were visualized by application of the solvatochromic fluorescent dye Nile Red, which undergoes emission spectra changes dependent on its environment, and used here for the first time to detect underlying axo-glial injury. Live imaging of dorsal column fibres from cervical spinal cord revealed YFP + axon profiles ensheathed in myelin (Nile Red) that appeared morphologically normal in naïve control conditions up to 8 h after ablation ( Fig. 1A and B) . To reliably transect a discrete number of dorsal column fibres we performed laser-induced SCI. An area measuring $20 Â 20 mm on the dorsal surface of the spinal cord was irradiated 10 times in rapid succession with 800 nm pulsed light at 600 mW (measured at the scanhead) creating a well-defined and reproducible lesion. The transected axons (primary injury) formed swollen endbulbs both rostral and caudal to injury and retracted up to 100 mm during a standard 4-h observation period (Fig. 1C ). In addition, fibres adjacent to the ablation site that survived the initial injury later succumbed to secondary 'bystander' degeneration ( Fig. 1D) . Importantly, the width of secondary axonal loss significantly (P 5 0.001) increased from 5 min (7.33 AE 1.05 mm, mean AE SEM) to 4 h (21.60 AE 1.95 mm) after laser-induced SCI representing an $195% increase in spared adjacent fibre loss at 4 h (Fig. 1E ). These data suggest that substantial numbers of axons that http://brain.oxfordjournals.org/ survived the original laser ablation succumbed to secondary degeneration in a delayed fashion. Importantly, we were able to follow this dynamic response using time-lapse microscopy and clearly distinguish between primary versus secondary injured axons as the primary injury site, did not change (P = 0.25, P = 0.55, respectively) over time ( Fig. 1E and F) . Under control conditions, microglia (GFP + ) were highly ramified and frequently extended/retracted their processes parallel to ascending myelinated fibres ( Fig. 2A ) (Davalos et al., 2005; Nimmerjahn et al., 2005; Dibaj et al., 2010) . In contrast, microglia in the vicinity of laser-induced SCI responded within minutes by orienting and directing their processes towards the ablation site (Fig. 2B , C and F; Supplementary Video 1). Using spectral confocal imaging and subsequent 'unmixing' of multiple overlapping fluorescent proteins and dyes using algorithms generated by P.K.S (see 'Materials and methods' section and Fig. 3 ), we were able to document that microglial processes (GFP + ) were in intimate contact with retracting axonal end bulbs (red-shifted protein staining of Nile Red; Figs 2D and 3), damaged ballooning myelin (Nile Red), and clearly phagocytosed myelin debris (Fig. 2E ). Microglia were also localized to degenerating YFP-positive axons (spectral unmixing of YFP axons and GFP microglia; Fig. 3A -D) and contacted myelin spheroids and retracting axonal endbulbs ( Fig. 3E-H) . Thus, recordings of live spinal white matter revealed that reactive microglia (shorter, thicker processes) were intimately associated with myelin (Nile Red) and axons (spectral shift Nile Red) undergoing pathophysiological changes within the first 4 h after laser-induced SCI, a pattern that was not observed during baseline conditions.
Effects of microglial modulation on the microglial response to laser-induced spinal cord injury
To prevent microglial-mediated white matter injury we targeted microglial release of neurotoxic molecules using the group III metabotropic glutamate receptor agonist L-AP4, and glutamate release through gap junctions with carbenoxolone. Conversely, stimulating microglia with potent sterile pro-inflammatory TLR agonists (e.g. lipopolysaccharide, TLR4 agonist; zymosan, TLR2/ dectin-1 receptor agonist) that have been previously shown to increase glutamate, nitric oxide, free radical, and cytokine release from microglia/macrophages would augment white matter injury (Fitch et al., 1999; Lehnardt et al., 2002; Popovich et al., 2002; Takeuchi et al., 2005) . As zymosan can activate both TLR2 and dectin-1 receptors (Brown et al., 2003) we also assessed the pure synthetic lipopeptide, Pam2CSK4, as a specific and potent activator of TLR2 receptors (van Bergenhenegouwen et al., 2013) . The treatment groups are detailed in Table 1 . As shown in Fig. 4 , the mean microglial response to laserinduced SCI was robustly enhanced by pretreatment (30 min) with TLR agonists. Specifically, the Pam2CSK4-stimulated microglial response doubled from 2 min (13.30 AE 2.86; mean response AE SEM) and remained significantly increased up to 4 h (27.00 AE 5.23) after laser-induced SCI when compared with artificial CSF controls (3.42 AE 0.78 and 9.93 AE 1.51 at 2 min and 4 h, respectively, n = 4 per treatment group, P 5 0.05) (Fig. 4A and B and Supplementary Video 2). Lipopolysaccharide modulation also significantly increased the microglial response to laser-induced SCI versus artificial CSF controls from 2 h until 4 h after laser-induced SCI (lipopolysaccharide, 31.51 AE 2.35; artificial CSF, 9.93 AE 1.51, n = 4 per group, P 5 0.05), albeit in a delayed manner compared with Pam2CSK4 treatment (Fig. 4A and B) . In contrast to these note the extensive degree of spectral overlap that would be difficult to separate using conventional dichroics and emissions filters. Each pixel in the resulting spectral image contained 32 channels of spectrally resolved data that was loaded into our unmixing algorithm (written by P.K.S.). (E-G) Spectral images of the living dorsal surface of the spinal cord from a Cx3cr1GFP/ + transgenic mouse stained with the lipophilic solvatochromic Nile Red (NR) and captured at 4 h after laser-induced SCI. Nile Red undergoes spectral shifts dependent on the chemical environment in which the dye is exposed to and these shifts can be 'unmixed' even if their emission maxima are separated by only 10 nm. Nile Red's emission spectrum is blue-shifted in the less polar, more lipid-rich environment of adipocytes (hashed line, H) and normal CNS myelin (green, E-H). In contrast, Nile Red's emission spectrum peaks at $625 nm [$40-50 nm shift compared to normal myelin ($580-590 nm)] in axonal endbulbs undergoing axonal dieback suggestive of underlying changes in protein accumulation or disorganization revealing presumably hydrophobic binding sites (red, E-H). Microglia (blue) are shown in close proximity to myelin spheroids (Nile Red, green) and axonal endbulbs (Nile Red shifted, red) and may influence secondary myelin and axonal degeneration after injury. Representative images and emission spectra from n = 5 mice. Scale bar = 10 mm. results, L-AP4, carbenoxolone (data not shown), zymosan, or cycloheximide (data not shown) pretreatment did not significantly alter the microglial response to laser-induced SCI versus artificial CSF controls. These data support the concept that the microglial response (timing and quantity of microglial process extension) to laser-induced SCI can be enhanced effectively using specific TLR2 and -4 agonists.
Effects of microglial modulation on acute axonal dieback following laser-induced spinal cord injury Before laser-induced SCI there were no significant differences (P = 0.19) in the microglial response between any of the microglial modulators compared to artificial CSF controls. The specific TLR2 agonist Pam2CSK4 significantly (P 5 0.01) increased the microglial response to laser-induced SCI at 2 min through to 4 h after laser-induced SCI versus controls. Lipopolysaccharide stimulation increased (P 5 0.05) the microglial response to injury in a delayed manner compared with Pam2CSK4 treatment, beginning at 2 h until 4 h after injury. Neither zymosan or L-AP4 altered the microglial response (P 4 0.05). Data are represented as mean AE SEM, n = 4-5 animals per group. One-way ANOVA, Holm-Sidak method of multiple comparisons versus control group. *P 5 0.05. from the lesion epicentre after SCI. Although the precise mechanisms that mediate axonal dieback after SCI remain unknown, anti-inflammatory treatment of SCI-rats with minocycline or methylprednisolone reduced both the CNS macrophage response and the late phase of axonal dieback (Oudega et al., 1999; Stirling et al., 2004) . Furthermore, clodronate liposome-mediated depletion of blood-derived macrophages prior to SCI confirmed a role for macrophages in mediating late phase axonal dieback (Horn et al., 2008) . However, whether microglial cells per se contribute to SCI-induced acute or late phase axonal dieback remains unknown.
To examine the role of microglia in acute axonal dieback we applied microglial modulators and quantified axonal dieback over time by recording the distance between the ablation edge and the endbulbs utilizing two-photon excitation time-lapse video microscopy. Only endbulbs in continuity with their proximal axons were included in our analysis to rule out axons undergoing acute Wallerian-like degeneration. The latter were easily distinguishable from actively retracting axons as fragmented axonal segments were discontinuous in the z-plane and had faded YFP expression. Unexpectedly, microglial stimulation by the TLR2 agonist Pam2CSK4, that robustly increased the microglial response to laser-induced SCI and in distinction to the other microglial modulators, significantly reduced proximal axonal dieback (Fig. 5A-C) . Representative images from two-photon excitation time-lapse recordings 4 h after laser-induced SCI are shown for each of the treatment groups and Tlr2KO: Thy1YFP + double transgenic mice (Fig. 5A ). Cumulative distribution of endbulbs as a function of distance from the lesion edge at 1 h and 4 h (Fig. 5B ) revealed that Pam2CSK4 treatment shifts the distribution curves to the left, i.e. less axonal retraction/dieback, whereas both Tlr2KO:Thy1YFP + double transgenic mice and zymosan treatment shifted the curve to the right suggestive of greater axonal retraction versus control (artificial CSF) (Fig. 5B) . Quantitation of these results confirmed that Pam2CSK4 treatment significantly reduced proximal axonal dieback at 1 h and 4 h following laser-induced SCI compared to artificial CSF treated controls whereas zymosan and Tlr2KO:Thy1YFP + double transgenic mice significantly worsened axonal retraction (Fig. 5C ). In contrast to these results, microglial modulation with L-AP4, cycloheximide (data not shown) or carbenoxolone (data not shown) did not prevent axonal dieback. Indeed, the latter induced robust acute Wallerian-like degeneration (pan-fragmentation) of the transected fibres within the first 2 to 4 h after laser-induced SCI (Fig. 6) . Together, these results suggest that inducing a robust microglial response with the specific TLR2 agonist Pam2CSK4, but not zymosan or lipopolysaccharide, greatly reduces laser-induced SCI-induced axonal dieback; a necessary prerequisite for growth cone formation and subsequent axonal regeneration. Conversely, treatments that target microglial glutamate release were ineffective at reducing axonal dieback. Furthermore, the exacerbated axonopathy in Tlr2KO:Thy1YFP + double transgenic mice at 4 h after laser-induced SCI likely contributes to the worsened neurological outcome in Tlr2KO mice after contusion SCI (Kigerl et al., 2007) . 
Effects of microglial modulation on secondary 'bystander' degeneration of spared axons after laser-induced spinal cord injury
To further examine the neuroprotective effects of Pam2CSK4 we measured the width of axonal loss (i.e. 'bystander' loss) of adjacent axons that survived the primary injury but succumbed to secondary degeneration over time as revealed by time-lapse recordings of the ablation site. As shown in Fig. 7 , Pam2CSK4 treatment significantly reduced secondary 'bystander' degeneration of adjacent fibres at 30 min and 4 h (Pam2CSK4; 13.06 AE 1.413, mean AE SEM) after laser-induced SCI compared to artificial CSF controls (21.6 AE 1.95) ( Fig. 7A and B) . In contrast, zymosan, a TLR2/dectin-1 receptor antagonist increased lesion width at 5 min after laser-induced SCI and continued a strong trend to an increase in bystander loss of axons from 30 min to 4 h after injury ( Fig. 7A and B) . Similarly to zymosan, Tlr2KO:Thy1YFP + double transgenic mice experienced an acute increase in the width of axonal loss compared to artificial CSF controls; however, this did not reach significance. Lipopolysaccharide, a TLR4 agonist, despite greatly increasing the microglial response to laser-induced SCI (Fig. 3) , did not prevent myelinated fibres from undergoing secondary degeneration ( Fig. 7A and B). Neither microglia modulation with the group III metabotropic glutamate receptor receptor agonist L-AP4, that has been previously shown to promote a protective microglia phenotype; carbenoxolone, that has been previously shown to reduce microglial glutamate release; nor cycloheximide, an inhibitor of protein synthesis, prevented bystander loss of myelinated fibres acutely after laser-induced SCI (Fig. 7C) .
Effects of microglial modulation on microglial phenotype
Given the beneficial effects on white matter sparing by stimulating microglia with Pam2CSK4, we next assessed whether microglial modulation altered their pro-inflammatory repertoire. Research in models of infection and disease support the concept that macrophages can be polarized to classical (M1, pro-inflammatory) or alternative (M2, anti-inflammatory) activated states (Gordon, 2003) . In the SCI setting, M1 macrophages dominate the lesion site and remain elevated up to 6 weeks after SCI, whereas M2 macrophages are scarce at later time points (Kigerl et al., 2009) . Blocking M1 recruitment promotes alternatively activated M2 macrophage recruitment and improves neurological outcome after SCI (Guerrero et al., 2012) . However, whether true microglia heterogeneity per se exists or whether they can be polarized after SCI and the resultant outcome on destructive or reparative processes remains unclear. Towards this goal, we prepared single cell preparations of spinal cord white matter from sham, Pam2CSK4-treated and endotoxin-free water control-treated dorsal columns at 4 h after laser-induced SCI and assessed the amount of inflammatory microglia (CD45 As shown in Fig. 9C , several markers of inflammation were altered after laser-induced SCI. Specifically, inflammatory markers CCL2, IL1-beta, inducible nitric oxide synthase, SOCS1 and 3, and IL-1ra were significantly elevated in Pam2CSK4-treated spinal cords versus sham controls and inducible nitric oxide synthase, SOCS3 and IL-1ra were significantly increased in Pam2CSK4 treated spinal cords versus laser-induced SCI controls (Fig. 9C) . Interestingly, markers of the M2 alternative activation pathway (arginase 1, IL-10, mannose receptor, CD206) were 2 to 3-fold higher in Pam2CSK4-treated cords versus laser-induced SCI controls, however, only SOCS3 and IL-1ra levels reached significance. Pam2CSK4-treatment reduced the laser-induced SCI-induced increase in Ly6C expression in microglia, a marker of classically activated monoctyes (M1), and altered the inflammatory milieu following laser-induced SCI. We found very little evidence of a true M1 versus M2 phenotype in microglia but rather an 'alternative' activation profile within the two extremes where both M1 (inducible nitric oxide synthase) and M2 (SOCS3, IL1ra) markers were elevated acutely with treatment. Pam2CSK4 applied to sham controls did not affect gene expression.
Collectively, Pam2CSK4 treatment robustly increased the microglial response to laser-induced SCI and reduced axonal dieback and secondary 'bystander' loss of axons adjacent to the lesion site. Moreover, Pam2CSK4 treatment altered the inflammatory milieu of microglia (less Ly6C + expressing microglia), cytokine and M1, M2 marker expression by inducing concurrent proinflammatory and anti-inflammatory molecules that together promote white matter sparing after laser-induced SCI. Thus treatments designed to inhibit the microglial response to white matter injury seem counter-intuitive when both the inflammatory response and effects on white matter sparing are assessed in realtime acutely after injury. Representative two-photon excitation images of YFP + axons (green) and myelin (Nile Red, red) from time-lapse recordings at 4 h after laser-induced SCI. Laser-induced SCI induces secondary 'bystander' degeneration of myelinated fibres adjacent to ablation site (red circle in centre of image). Scale bar = 10 mm. The white arrows indicate the amount of secondary axonal loss adjacent to the lesion. (B and C) Quantitation of axonal loss (secondary 'bystander' axonal degeneration), as a function of time after laser-induced SCI. Pam2CSK4 treatment significantly reduced lesion width at 30 min and 4 h after injury compared with artificial CSF (aCSF) controls (B). The TLR2/ dectin-1 agonist, zymosan (ZYM), significantly increased lesion width at 5 min after laser-induced SCI. Lipopolysaccharide (LPS) stimulation of TLR4 receptors did not alter lesion width compared with controls. (C) Inhibiting the microglial response with L-AP4, carbenoxolone or cycloheximide did not reduce bystander loss of axons after laser-induced SCI. Data are represented as mean AE SEM for each treatment group. Statistical significance was assessed using a one-way ANOVA with Holm-Sidak method for multiple comparisons or in the case of unequal variances, a Kruskal-Wallis one-way ANOVA on Ranks with Dunn's method of multiple comparisons. n = 4-14 spinal cords per treatment group. *P 5 0.05. TLR2 modulation of microglia after SCI Brain 2013: Page 11 of 17 | 11
Discussion
After CNS trauma microglia are rapidly recruited to the site of injury followed by the recruitment of neutrophils and subsets of blood-derived macrophages that populate the lesion site over time (Dusart and Schwab, 1994; Kigerl et al., 2009) . In addition, perivascular macrophages and leptomeningeal macrophages likely add to this global myeloid response to injury once the protective CNS barriers are breached. The function of these divergent myeloid populations, their temporal and spatial (lesion border versus lesion cavity) accumulation, arsenal of potential neurotoxic and wound healing molecules, and the local inflammatory milieu that regulates their function within the injured CNS remains poorly understood.
Given the recently appreciated and tremendous plasticity of myeloid cells (i.e. classically activated pro-inflammatory M1 monocytes, alternatively activated M2 monocytes, myeloid-derived suppressor cells) (Sica and Mantovani, 2012) , the difficulty to specifically target these subpopulations, and treatment paradigms that globally inhibit or augment their response, may underlie the many discrepancies with regards to the role of macrophages in the field of CNS injury (David and Kroner, 2011) . Thus, a better understanding of these divergent subpopulations of microglia/macrophages and their function in the injured CNS setting will be necessary to maximize wound healing and regenerative processes without causing overt neurotoxicity. At present there is no absolute way to separate the microglial response from hematogenous macrophages experimentally or after human SCI. Because of this limitation, our knowledge of the role of resident CNS microglia in , and (C) laserinduced SCI Pam2CSK4 (PAM2) treatment. Representative light scatterplots from each of the groups is shown (side scatter, y-axis: forward scatter, x-axis, far left) and the gates used to quantify CD45low:CD11b positive microglia (bottom ellipse, middle panel) and CD45high:CD11b positive macrophages (top ellipse, middle panels) as determined from isotype controls (not shown). Plots of Ly6C + microglia from the population of CD45low:CD11b microglia are shown on the far right for each treatment group. Total counts of the population of microglia that express Ly6C high levels are shown for the various treatment groups. Representative plots and histograms from a total of n = 4 animals/group. SCI in general is poorly understood. Thus we purposely developed this ex vivo model to better understand the role of microglia in white matter injury, without the confounding effects of bloodderived myeloid responses. By understanding the unique roles of CNS-resident versus blood-borne cells in more detail may encourage or discourage manipulations to target individual subsets depending on the magnitude and effect of each macrophage compartment.
Using two-photon excitation time-lapse video microscopy and spectral microscopy, we demonstrated that microglia rapidly respond to laser-induced SCI by extending their processes to presumably seal off the lesion area as previously shown following penetrating brain injury (Hines et al., 2009) . These results are in agreement with a previous study that assessed the microglial response to SCI in vivo suggestive that the ex vivo model used here recapitulates the microglial response in vivo (Dibaj et al., 2010) . Our model of axonal injury also closely mimics the axonopathy described in well-characterized clinically relevant models of SCI including contusive, compressive, and transection based models. In support, dorsal column transection in vivo induces endbulb formation on transected ascending sensory fibres with morphologies identical to ours (Erturk et al., 2007) . These structures often appear round and/or oval at the proximal cut end of the axon with diameters larger than the proximal axonal shaft with no growth-cone like extensions [c.f. Fig. 1F and G in Erturk et al. (2007) using an in vivo transection SCI model with our data in Figs 1C, D and 5A] .
Similarly, acute ultrastructural studies reported that at 4 h after weight drop contusion SCI, the formation of 'terminal clubs' or endbulbs represented severed axons and were scattered predominantly in white matter (Wagner et al., 1978) . Alike to contusion SCI, proximal stubs of sheared or transected axons formed swollen endbulbs (retraction bulbs) identical to what we describe in our laser-induced SCI model (Kao et al., 1977) . Moreover, in a quantitative assessment of acute changes in axonal injury following spinal cord compression injury, Anthes et al. (1995) described several axonal changes especially within the first few hours after injury. These were peri-axonal swelling (i.e. an increase in the periaxonal space between the axolemma and surrounding myelin sheath), myelin vesiculation and rupturing, organelle accumulation in axons surrounding a neurofilamentous axonal core, and terminal swollen axonal endbulbs. Of note, terminal endbulb formation, swollen myelin, and periaxonal swelling, are key features of acute pathological changes in axons following our laser-induced SCI model (see Fig. 5 for example). Lastly, axonal spheroid formation and axonal endbulb formation has been recognized previously in both compressive, contusive, and transection based SCI models (Kao et al., 1977; Balentine, 1978; Bresnahan, 1978) and is thought to result from the injury itself, or subsequent resealing of sheared, ruptured or transected axons and accumulation of organelles (Anthes et al., 1995) . Thus, our laser-induced SCI model mimics acute axonal changes seen in more clinically relevant models of SCI; however, the spatiotemporal precision and submicron level of resolution in our model is a major advantage and allows direct visualization of these dynamic changes as they are occurring in real-time, not possible with assessments of static sections.
Here we reveal that the microglial response to laser-induced SCI occurred in parallel to secondary axonal degeneration in real time and microglial processes were intimately associated with axonal dieback and secondary axonal degeneration, and ballooning myelin. We also found that spectral microscopy is a powerful tool to visualize spectral shifts in solvatochromatic fluorescent dyes such as Nile Red, whose fluorescence is highly dependent on the polarity of its environment and can be used to differentially detect highly lipophilic structures such as myelin, and the unveiling of hydrophobic protein surfaces (Sackett and Wolff, 1987) that likely appear in endbulbs after injury.
In support, we uncover a novel spectral shift in the emission of Nile Red between axonal endbulbs, undergoing axonal dieback and myelin that can be spectrally resolved to allow specific visualization and changes in these structures as they undergo degeneration. These Nile Red spectral changes in endbulbs may represent accumulation of proteins (e.g. amyloid precursor protein) or the hydrophobic surfaces of tubulin that are known to be present in stumps of transected axons acutely during endbulb formation (Sackett et al., 1990; Erturk et al., 2007) . Equally important is the ability to differentiate between several closely overlapping emission spectra (i.e. YFP, GFP) allowing the unequivocal identification of several cell types simultaneously within the injured CNS. Further work using these novel tools will be necessary to determine the identity and significance of these acute pathological changes in axons following injury in real-time.
Counter to our hypothesis, microglia modulation through sterile targeting of TLR2 receptors using Pam2CSK4 greatly increased the microglial response to laser-induced SCI, altered the inflammatory milieu of the injured spinal cord, but surprisingly reduced secondary degeneration of myelinated fibres. These neuroprotective outcomes after Pam2CSK4 treatment were associated with reduced Ly6C expression (a common marker of M1 pro-inflammatory monocytes) in microglia and a mixed phenotype of M1:M2 (both pro and anti-inflammatory) molecules isolated from injured white matter. However, it is important to note that our analyses were largely at 4 h after injury, an early time point where markers of protein expression such as MHCII, CD80 and CD86 are all likely to be inconclusive to completely resolve M1 and M2 phenotype. Thus, we resorted to PCR analyses, as messenger RNA changes precede protein alterations for the markers presented in Fig. 9 . Our data indicate that M1 and M2 markers are both elevated at the 4-h time point, indicating that at this very early period of injury ex vivo, M1 and M2 transcripts are concordantly elevated; it is possible that mixed elevation occurs at early periods (hours) after injury, and that it is not reported by others as their analyses typically involve specimens collected days after the insult (Kigerl et al., 2009) .
Interestingly, Pam2CSK4 treatment induced upregulation of inducible nitric oxide synthase and presumably induced release of nitric oxide and other pro-inflammatory molecules (e.g. IL1B) (Fig. 9) that have been previously shown to contribute to CNS injury (David and Kroner, 2011) . Although the newly described Ly6C low : inducible nitric oxide synthase-positive macrophages may contribute to secondary degeneration at later time-points after SCI (Donnelly et al., 2011) , the Pam2CSK4-induced inducible nitric oxide synthase expressing microglia acutely after SCI (current study) may be beneficial by sealing of the lesion site and preventing secondary degeneration. In support, nitric oxide regulates white matter spinal cord microglial process extension towards sites of injury in vivo (Dibaj et al., 2010) and inhibiting microglial process extension exacerbates lesion size after brain injury (Hines et al., 2009 ). Concurrently to M1 marker expression, potent antiinflammatory molecules (i.e. SOCS1 and 3 and IL-1ra) were significantly increased in Pam2CSK4 treated animals versus controls. The suppressor of cytokine signalling (SOCS) proteins are potent attenuators of TLR mediated responses in immune cells (Baker et al., 2009) , and IL-1ra is a potent inhibitor of IL1B signalling and prevents IL1B induced white matter injury after SCI (Nesic et al., 2001) . Thus Pam2CSK4-induced upregulation of SOCS and IL-1ra may downregulate the release of microglial-derived toxins and M1-like macrophage polarization. Collectively, the increase in both M1 and M2 markers and lack of blood-derived monocytes suggest a novel functional alternatively activated microglial phenotype that can be modulated in situ and is associated with reduced secondary white matter injury. Importantly, we found no evidence to support a pure M1 or M2 phenotype in microglia at 4 h after laser-induced SCI but rather a mixed phenotype within the two extremes as both M1-like and M2-like markers were present and there was no distinction between Ly6C high and Ly6C low expression in living spinal cord as has been shown for monocytes in peripheral tissues. Although microglia were the focus of this study and respond robustly to TLR agonists in brain (Rivest, 2003) , it is important to note that we cannot exclude the possible contribution of other glial cells to acute axonal injury. However, controversy exists with regards to astrocyte expression of TLR2, pro-inflammatory and chemokine transcripts are typically localized to microglia within the first few hours of immune challenge or CNS injury (Babcock et al., 2003; Rivest, 2003) , and endothelial cells weakly respond to TLR2 agonists (Faure et al., 2000) . Future studies will be needed to examine the interactions between microglia and astrocytes as the former can influence the latter's response to inflammatory stimuli. In contrast to these results, treatments that have been previously shown to inhibit microglial mediated release of neurotoxic molecules (i.e. carbenoxolone and L-AP4) failed to protect the injured spinal cord in the current study and are at odds with previous in vitro and in vivo studies that have shown that microglia contribute to white matter injury (Park et al., 2004; Takeuchi et al., 2005; Domercq et al., 2007 , Pinteaux-Jones et al., 2008 . Although the reasons behind these discrepancies remain unknown, it is possible that in our ex vivo model the microglial release of potentially neurotoxic molecules is tightly regulated by factors released by surrounding cells (Aguzzi et al., 2013) ; therefore, neurotoxin release may be dampened compared with TLR agonist stimulation of microglia in vitro that lacks this regulation. Therefore, under these conditions it is plausible that L-AP4 and carbenoxolone would have no obvious effect. Alternatively, given the acute endpoint in our study, we may have missed subsequent release of potential neurotoxic molecules at later time-points that may have induced white matter injury. These discrepancies may also underlie the important pathological role that blood-derived macrophages may play in vivo at later time points following CNS injury and the need for ex vivo and in vivo models to interrogate the true role of microglia in white matter injury as the local environment likely shapes their response which is unobtainable in cell culture based paradigms.
Although our laser-induced SCI model mimics axonopathy of well-characterized in vivo SCI models (as discussed above), we cannot exclude a potential priming effect on microglia and axons as the spinal cord was extracted and thus the response to a subsequent injury (i.e. laser-induced SCI) may be altered. Nonetheless, several observations counter this conclusion. First, a key indicator of CNS trauma or disease is microglia themselves that undergo stereotypical changes in their morphology as they respond to CNS disturbances (Ransohoff and Perry, 2009) . As shown in our live imaging studies (Fig. 2) , microglia had highly ramified processes that extended and retracted over time and appeared identical to those shown following in vivo observations of the exposed brain or spinal cord (Davalos et al., 2005; Nimmerjahn et al., 2005; Hines et al., 2009; Dibaj et al., 2010) , and in tissue sections from non-injured spinal cord (Stirling and Yong, 2008) . Second, following laser-induced injury in brain and spinal cord in vivo or following pin-prick injury, microglia become activated and send out their processes to seal of the injury site (Davalos et al., 2005; Nimmerjahn et al., 2005; Hines et al., 2009; Dibaj et al., 2010) . The spatiotemporal microglial responses in these models are identical in magnitude to the current study. Third, in non-injured conditions in the present study key inflammatory markers were at low or undetectable levels as were markers of microglial activation (Fig. 9 in the current study) parallel to controls used for in vivo contusive SCI studies (McTigue et al., 1998; Lee et al., 2000; Pineau and Lacroix, 2007; Rice et al., 2007) . Thus, microglia seem not to be activated, nor are inflammatory markers present in this model initially, but both increase after laser-induced SCI as they do following other well-characterized SCI models (Lee et al., 2000; Diaz-Ruiz et al., 2002; Yang et al., 2005; Pineau and Lacroix, 2007) . Lastly, axon injury responses such as swelling, spheroid formation, and axonal endbulb formation occurred at similar time-points (within 2-3 h) as shown after in vivo compressive or contusive SCI injuries (Kao et al., 1977; Balentine, 1978; Anthes et al., 1995) . Collectively, the lack of microglia activation, inflammatory markers, and similar time course of inflammatory reactions and axonal changes in our laser-induced SCI as shown for contusion SCI in vivo suggest the removal of the spinal cord and loss of descending responses from the brain did not significantly impact the results of our study at least at the time-points examined.
In summary, we imaged microglial activation and subsequent axon and myelin pathology in real-time using advanced imaging techniques such as two-photon microscopy and spectral microscopy. We developed a powerful injury model, laser-induced SCI, that allows one to document dynamic processes such as axonal dieback and secondary degeneration of spared fibres with excellent spatio-temporal resolution. Together, these data strongly suggest that promoting beneficial sterile inflammation by the TLR2 agonist Pam2CSK4, induces a robust microglial response that is neuroprotective after laser-induced SCI. Thus, inhibiting the microglial response acutely after SCI with anti-inflammatory treatments may be counter-intuitive, as revealed for L-AP4 and carbenoxolone in the current study.
Importantly, the laser-induced SCI model combined with fluorescent proteins and lipophilic fluorescent dyes allows one to clearly distinguish primary from secondary degeneration, which is difficult to accomplish using other in vivo models. It therefore may provide an important stepping-stone to quickly and accurately test the effects of putative neuroprotective agents and document the dynamic changes in axons and myelin as these events are unfolding in real time. Ultimately, the results from the current work have identified TLR2 stimulation of microglia as a novel therapeutic target for SCI. In addition, we provide the rationale to further test the efficacy of Pam2CSK4, and other TLR2 agonists, in delayed treatment paradigms using more clinically relevant models of SCI in which behavioural outcomes can be assessed and thereby rule out potential limitations in the current model such as the lack of blood-derived factors and immune cell http://brain.oxfordjournals.org/ recruitment that may alter the response of microglia to TLR2 stimulation. There is a great need for efficacious neuroprotective treatments for patients with SCI. TLR2 agonists have also entered clinical trials (e.g. NCT01685489) for treating cancer and other conditions, and results from trials of TLR2 agonists have revealed both safety and efficacy in humans (Schmidt et al., 2007; Niebuhr et al., 2008) . It is hoped that the results of this study may lead to the development of more effective neuroprotective treatments for patients with SCI.
